Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 19/20 | 0.87 |
| ▸ | FGFR1 | P11362 | 11/20 | 0.87 |
| ▸ | KDR | P35968 | 11/20 | 0.87 |
| ▸ | INSR | P06213 | 5/20 | 0.72 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.51 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4036446 | 0.93 | IGF1R (1.00) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL2121062 | 0.90 | IGF1R (0.84) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL3870821 | 0.87 | IGF1R (0.82) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL4033971 | 0.86 | IGF1R (0.82) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL3865429 | 0.84 | IGF1R (1.00) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL4034969 | 0.83 | IGF1R (0.85) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL4208194 | 0.80 | IGF1R (1.00) | IGF1RFGFR1KDRINSR | |
| SCHEMBL2122642 | 0.79 | IGF1R (0.72) | IGF1RFGFR1KDRINSR | |
| SCHEMBL4035278 | 0.78 | IGF1R (0.83) | IGF1RFGFR1KDRINSRNTRK1 | |
| SCHEMBL3864859 | 0.78 | IGF1R (0.79) | IGF1RFGFR1KDRINSRNTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230035892-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FLAGSHIP PIONEERING, INC. | 2023-02-02 | — | — | US | disclosed |
| EP-1456182-B1 | PYRIMIDINE DERIVATIVES AS MODULATORS OF INSULINE-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-I) | ASTRAZENECA AB (SE) | 2009-03-11 | — | — | EP | disclosed |